FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Art Pappas will sit on a panel at the 2007 BIO International Convention titled "Mining for Gold: Top Biotech Venture Capital Markets" in Boston
News | 05. 06. 2007
